9月号「ACSM自己診断テスト♯71」の参考文献

2016年 09月 02日

ACSM自己診断テスト♯71「Physiological benefits of exercise in cancer patients；がん患者における運動の生理的有効性」の翻訳記事は、『ヘルスネットワーク』2016年9月号ｐ6～に掲載しています。

■本文の参考文献

1.  Al-Majid S, Waters H. The biological mechanisms of cancer-related skeletal muscle wasting: the role of progressive resistance exercise. Biol Res Nurs. 2008;10(1):7-20.

2.  Betof AS, et al. Modulation of murine breast tumor vascularity, hypoxia and chemotherapeutic response by exercise. J Natl Cancer Inst. 2015;107(5): 10.1093/jnci/djv040.

3.  Brown JC, et al. Cancer, physical activity, and exercise. Compr Physiol. 2012;2(4):2775-809.

4.  Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer. 2004;4(1):11-22.

5.  Gannon NP, et al. Effects of the exercise-inducible myokine irisin on malignant and non-malignant breast epithelial cell behavior in vitro. Int J Cancer. 2015;136(4):E197-202.

6.  Jones LW, et al. Effects of exercise training on antitumor efficacy of doxorubicin in MDA-MB-231 breast cancer xenografts. Clin Cancer Res. 2005;11(18):6695-8.

7.  Kruijsen-Jaarsma M, et al. Effects of exercise on immune function in patients with cancer: a systematic review. Exerc Immunol Rev. 2013;19:120-43.

8.  Lira FS, Neto JC, and Seelaender M. Exercise training as treatment in cancer cachexia. Appl Physiol Nutr Metab. 2014;39(6):679-86.

9.  Nieman DC. Marathon training and immune function. Sports Med. 2007;37(4-5):412-5.

10.  Salakari MR, et al. Effects of rehabilitation among patients with advanced cancer: a systematic review. Acta Oncol. 2015;54(5):618-28.

11.  Sparling PB, et al. Exercise activates the endocannabinoid system. Neuroreport. 2003;14(17):2209-11.

12.  Wolin KY, et al. Implementing the exercise guidelines for cancer survivors. J Support Oncol. 2012;10(5):171-7.

13.  Wonders KY, et al. Acute exercise protects against doxorubicin cardiotoxicity. Integr Cancer Ther. 2008;7(3):147-54.